Agnese Sembolini1, Michele Romoli2, Umberto Pannacci3, Giulio Gambaracci4, Piero Floridi5, Monica Acciarresi6, Giancarlo Agnelli6, Andrea Alberti6, Michele Venti6, Maurizio Paciaroni6, Valeria Caso6. 1. Emergency Medicine, Ravenna Hospital - AUSL Romagna, Rimini, Italy. 2. Neurology Unit, Rimini "Infermi" Hospital - AUSL Romagna, Rimini, Italy. michele.romoli@auslromagna.it. 3. Department of Medicine, University of Perugia, Perugia, Italy. 4. Radiology and Diagnostics, Assisi Hospital - USL Umbria1, Assisi, Italy. 5. Neuroradiology, University of Perugia - Santa Maria della Misericordia Hospital, Perugia, Italy. 6. Stroke Unit, University of Perugia - Santa Maria della Misericordia Hospital, Perugia, Italy.
Abstract
INTRODUCTION: Hematoma expansion (HE) after intracerebral hemorrhage (ICH) is associated with short-term mortality, but its impact on long-term prognosis is still unclear. The aim of this study was to evaluate the impact of HE on long-term survival and functional status after spontaneous ICH. METHODS: Consecutive patients admitted with spontaneous ICH were prospectively enrolled and followed up for a minimum of 2 years. We compared short-term (< 30 days) and long-term survival and functional status between ICH patients with HE (HE+) and those without (HE-). Main outcomes were mortality and poor outcome, defined as modified Rankin Scale ≥ 3. Secondary outcomes included recurrent ICH, admission to institutionalized care, and ischemic events (stroke, myocardial infarction, and systemic embolism). RESULTS: Overall, 140 patients were included (mean age 74.9 years, male 59.3%) and followed up for a mean of 2.25 years. HE+ patients (25.7%) had larger hematoma volume at admission (23.8 ml vs 15.3 ml, p < 0.05), higher NIHSS score (14.6 vs 10.5, p < 0.05) and higher cumulative mortality (59.3% vs 39.2%, p < 0.05) compared to HE- patients. Survival analysis showed that HE+ confers higher mortality and worse functional status at all time points. HE did not associate with secondary outcomes. DISCUSSION: HE translates into higher mortality and functional dependence over long-term follow-up. Strategies limiting HE might benefit long-term functional status.
INTRODUCTION:Hematoma expansion (HE) after intracerebral hemorrhage (ICH) is associated with short-term mortality, but its impact on long-term prognosis is still unclear. The aim of this study was to evaluate the impact of HE on long-term survival and functional status after spontaneous ICH. METHODS: Consecutive patients admitted with spontaneous ICH were prospectively enrolled and followed up for a minimum of 2 years. We compared short-term (< 30 days) and long-term survival and functional status between ICHpatients with HE (HE+) and those without (HE-). Main outcomes were mortality and poor outcome, defined as modified Rankin Scale ≥ 3. Secondary outcomes included recurrent ICH, admission to institutionalized care, and ischemic events (stroke, myocardial infarction, and systemic embolism). RESULTS: Overall, 140 patients were included (mean age 74.9 years, male 59.3%) and followed up for a mean of 2.25 years. HE+ patients (25.7%) had larger hematoma volume at admission (23.8 ml vs 15.3 ml, p < 0.05), higher NIHSS score (14.6 vs 10.5, p < 0.05) and higher cumulative mortality (59.3% vs 39.2%, p < 0.05) compared to HE- patients. Survival analysis showed that HE+ confers higher mortality and worse functional status at all time points. HE did not associate with secondary outcomes. DISCUSSION: HE translates into higher mortality and functional dependence over long-term follow-up. Strategies limiting HE might benefit long-term functional status.
Authors: Andrea Morotti; Dar Dowlatshahi; Gregoire Boulouis; Fahad Al-Ajlan; Andrew M Demchuk; Richard I Aviv; Liyang Yu; Kristin Schwab; Javier M Romero; M Edip Gurol; Anand Viswanathan; Christopher D Anderson; Yuchiao Chang; Steven M Greenberg; Adnan I Qureshi; Jonathan Rosand; Joshua N Goldstein Journal: Stroke Date: 2018-04-18 Impact factor: 7.914
Authors: J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo Journal: Stroke Date: 2015-05-28 Impact factor: 7.914
Authors: Georgios Tsivgoulis; Duncan Wilson; Aristeidis H Katsanos; João Sargento-Freitas; Cláudia Marques-Matos; Elsa Azevedo; Tomohide Adachi; Christian von der Brelie; Yoshifusa Aizawa; Hiroshi Abe; Hirofumi Tomita; Ken Okumura; Joji Hagii; David J Seiffge; Vasileios-Arsenios Lioutas; Christopher Traenka; Panayiotis Varelas; Ghazala Basir; Christos Krogias; Jan C Purrucker; Vijay K Sharma; Timolaos Rizos; Robert Mikulik; Oluwaseun A Sobowale; Kristian Barlinn; Hanne Sallinen; Nitin Goyal; Shin-Joe Yeh; Theodore Karapanayiotides; Teddy Y Wu; Konstantinos Vadikolias; Marc Ferrigno; Georgios Hadjigeorgiou; Rik Houben; Sotirios Giannopoulos; Floris H B M Schreuder; Jason J Chang; Luke A Perry; Maximilian Mehdorn; João-Pedro Marto; João Pinho; Jun Tanaka; Marion Boulanger; Rustam Al-Shahi Salman; Hans R Jäger; Clare Shakeshaft; Yusuke Yakushiji; Philip M C Choi; Julie Staals; Charlotte Cordonnier; Jiann-Shing Jeng; Roland Veltkamp; Dar Dowlatshahi; Stefan T Engelter; Adrian R Parry-Jones; Atte Meretoja; Panayiotis D Mitsias; Andrei V Alexandrov; Gareth Ambler; David J Werring Journal: Ann Neurol Date: 2018-10-25 Impact factor: 10.422
Authors: Rita V Krishnamurthi; Valery L Feigin; Mohammad H Forouzanfar; George A Mensah; Myles Connor; Derrick A Bennett; Andrew E Moran; Ralph L Sacco; Laurie M Anderson; Thomas Truelsen; Martin O'Donnell; Narayanaswamy Venketasubramanian; Suzanne Barker-Collo; Carlene M M Lawes; Wenzhi Wang; Yukito Shinohara; Emma Witt; Majid Ezzati; Mohsen Naghavi; Christopher Murray Journal: Lancet Glob Health Date: 2013-10-24 Impact factor: 26.763